From: Quality of life of patients with ADPKD—Toranomon PKD QOL study: cross-sectional study
PCS | MCS | RCS | TLKV | |||||
---|---|---|---|---|---|---|---|---|
Question | rs | p | rs | P | rs | P | rs | P |
Q1 | 0.313 | <0.001 | 0.127 | NS | 0.198 | <0.005 | −0.189 | <0.05 |
Q2 | 0.366 | <0.001 | 0.090 | NS | 0.337 | <0.001 | −0.148 | NS |
Q3 | 0.450 | <0.001 | 0.357 | <0.001 | 0.306 | <0.001 | −0.328 | <0.001 |
Q4 | 0.235 | 0.001 | 0.388 | <0.001 | 0.210 | <0.005 | 0.044 | NS |
Q5 | 0.274 | <0.001 | 0.379 | <0.001 | 0.133 | NS | −0.092 | NS |
Q6 | 0.189 | <0.05 | 0.135 | NS | 0.179 | <0.05 | 0.066 | NS |
Q7 | 0.290 | <0.001 | 0.267 | <0.001 | 0.126 | NS | −0.072 | NS |
Q8 | −0.009 | NS | 0.084 | NS | −0.009 | NS | 0.077 | NS |
Q9 | 0.116 | NS | 0.037 | NS | 0.003 | NS | −0.148 | NS |
Q10 | 0.007 | NS | 0.010 | NS | 0.004 | NS | 0.117 | NS |
Q11 | 0.162 | <0.05 | 0.095 | NS | 0.163 | <0.05 | −0.030 | NS |
Q12 | 0.266 | <0.001 | 0.163 | <0.05 | 0.017 | NS | −0.077 | NS |
Pain | −0.582 | <0.001 | −0.437 | <0.001 | −0.193 | <0.005 | −0.083 | NS |